Top Markets
#1 PulseChain PulseChain +44.89%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +17.88%
#3 RedStone RedStone +15.77%
#4 MarsCoin MarsCoin +13.40%
#5 SkyAI SkyAI +10.21%
#6 Lighter Lighter +9.20%
#7 Meteora Meteora +9.19%
#8 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +8.24%
#9 Monad Monad +7.59%
#10 OPENLOOT OPENLOOT +7.54%
Coin of the day
PulseChain PulseChain
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
Rangering i aksjer #28170
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
Aksjekurs
$0.5495
Sist synkronisert: 2025-05-15
Markedsverdi
$28.14M
Endring (1 dag)
4.70%
Endring (1 år)
0.00%
Land
US
Handel Enzo Biochem, Inc. (ENZ)

Kategori

Healthcare
Inntekter for Enzo Biochem, Inc. (ENZ)
Inntekter i Apr 2025 TTM: $27.48M
Ifølge de nyeste økonomiske rapportene til Enzo Biochem, Inc. er selskapets nåværende inntekter (TTM) $27.48M. I 2023 hadde selskapet inntekter på $31.06M en nedgang sammenlignet med inntektene i 2022, som var $107.07M. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Enzo Biochem, Inc. fra 2000 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $27.48M -13.89%
2024 $31.91M 2.72%
2023 $31.06M -70.99%
2022 $107.07M -9.05%
2021 $117.73M 54.87%
2020 $76.02M -6.34%
2019 $81.17M -22.48%
2018 $104.71M -2.87%
2017 $107.80M 4.90%
2016 $102.77M 5.30%
2015 $97.60M 1.72%
2014 $95.95M 2.39%
2013 $93.71M -9.10%
2012 $103.08M 1.03%
2011 $102.03M 5.10%
2010 $97.08M 8.38%
2009 $89.57M 15.14%
2008 $77.80M 47.04%
2007 $52.91M 32.85%
2006 $39.83M -8.24%
2005 $43.40M 4.22%
2004 $41.64M -21.08%
2003 $52.77M -2.31%
2002 $54.02M -7.52%
2001 $58.41M 16.75%
2000 $50.03M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B 168,547.86%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B 91,281.26%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B 9,752.87%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.55B 16,472.24%
US